Concepedia

Angiotensin Receptor Antagonist Regresses Left Ventricular Hypertrophy Associated with Diabetic Nephropathy in Dialysis Patients

Yoshihiko Kanno, Keiko Kaneko, Masaharu Kaneko, Syuhei Kotaki, Taku Mimura, Hiroshi Takane, Hiromichi Suzuki

Journal of Cardiovascular Pharmacology · 2004 · 39 citations · 23 references

DOI

Abstract

An AT 1 antagonist, losartan, is beneficial for the regression of LVH in diabetic patients who started dialysis therapy under adequate blood pressure control.

References

23

Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.

David J. Sahn, A N Demaria, Joseph Kisslo et al. · Circulation · 1978 · 7.5K citations · Full text

, , +20

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Barry M. Brenner, Mark E. Cooper, Dick de Zeeuw et al. · New England Journal of Medicine · 2001 · 7.4K citations · Full text

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial

Lennart Hansson, Alberto Zanchetti, S. George Carruthers et al. · The Lancet · 1998 · 5.8K citations

, , +12

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Björn Dahlöf, Richard B. Devereux, Sverre E. Kjeldsen et al. · The Lancet · 2002 · 5.4K citations

, , +7

Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.

R DEVEREUX, Nathaniel Reichek · Circulation · 1977 · 4.5K citations · Full text

, , +18